Summary
reviewing under Chevron letter decision construing term "active ingredient" in ANDA provision, 21 U.S.C. § 355(j)(D),
Summary of this case from Mylan Laboratories, Inc. v. ThompsonOpinion
No. 90-1905.
October 7, 1991.
C.A. 9th Cir. Certiorari denied. Reported below: 921 F. 2d 280.